| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2025 | Apr 4, 2025 | Aprea Therapeutics, Inc. | CEO | Buy | 78.8 | +5,500 | 1.61% | ✗ | $10.1K |
| Oct 23, 2024 | Oct 24, 2024 | Aprea Therapeutics, Inc. | CEO | Buy | 55.0 | +500 | 0.15% | ✗ | $2K |
| Oct 15, 2024 | Oct 16, 2024 | Aprea Therapeutics, Inc. | CEO | Buy | 55.0 | +250 | 0.07% | ✗ | $725 |
| Oct 10, 2024 | Oct 15, 2024 | Aprea Therapeutics, Inc. | CEO | Buy | 60.0 | +1,150 | 0.35% | ✗ | $3K |
| Mar 13, 2024 | Mar 14, 2024 | Aprea Therapeutics, Inc. | CEO | Buy | 68.8 | +2,000 | 0.62% | ✗ | $14.6K |